[go: up one dir, main page]

ES556785A0 - Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2). - Google Patents

Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Info

Publication number
ES556785A0
ES556785A0 ES556785A ES556785A ES556785A0 ES 556785 A0 ES556785 A0 ES 556785A0 ES 556785 A ES556785 A ES 556785A ES 556785 A ES556785 A ES 556785A ES 556785 A0 ES556785 A0 ES 556785A0
Authority
ES
Spain
Prior art keywords
lymphocine
preparing
procedure
pharmaceutical composition
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556785A
Other languages
English (en)
Other versions
ES8801582A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59236357A external-priority patent/JPS61115099A/ja
Priority claimed from JP59236356A external-priority patent/JPH0811759B2/ja
Priority claimed from JP60028396A external-priority patent/JPS61115026A/ja
Priority claimed from JP60166754A external-priority patent/JPS61115028A/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of ES8801582A1 publication Critical patent/ES8801582A1/es
Publication of ES556785A0 publication Critical patent/ES556785A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES556785A 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2). Expired ES8801582A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP59236357A JPS61115099A (ja) 1984-11-09 1984-11-09 モノクロ−ナル抗体とその製法
JP59236356A JPH0811759B2 (ja) 1984-11-09 1984-11-09 新リンホカイン▲ｉｉ▼とその製法および用途
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン２の製造方法
JP60166754A JPS61115028A (ja) 1985-07-30 1985-07-30 抗腫瘍効果増強剤

Publications (2)

Publication Number Publication Date
ES8801582A1 ES8801582A1 (es) 1988-02-16
ES556785A0 true ES556785A0 (es) 1988-02-16

Family

ID=27458873

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548727A Expired ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)
ES556785A Expired ES8801582A1 (es) 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES548727A Expired ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)

Country Status (11)

Country Link
US (4) US5019385A (es)
KR (1) KR930004596B1 (es)
AT (1) AT395017B (es)
AU (1) AU603053B2 (es)
CH (1) CH664574A5 (es)
DE (1) DE3539775C2 (es)
ES (2) ES8703161A1 (es)
FR (1) FR2572936B1 (es)
GB (1) GB2168355B (es)
IT (1) IT1184668B (es)
SE (1) SE468853B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
NZ520392A (en) * 2000-02-10 2005-04-29 Abbott Lab Antibodies that bind human interleukin-18 and methods of making and using
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US9107879B1 (en) * 2010-04-01 2015-08-18 Vanderbilt University Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164964A (en) * 1967-04-20 1969-09-24 Ceskoslovenska Akademie Ved A Method of Cultivation of Animal Cells, and Apparatus for Carrying Out the Said Method.
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
JPS59116231A (ja) * 1982-12-13 1984-07-05 スロ−ン−ケツタリング・インステイテユ−ト・フオ−・キヤンサ−・リサ−チ 抗−インタ−ロイキン−２単クロ−ン抗体
DE3329449A1 (de) * 1983-08-16 1985-03-07 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Monoklonaler antikoerper, der eine struktur erkennt, die dem human-interleukin-2 (tcgf) und der leichten kette (lambda) von humanimmunglobulin gemeinsam ist, und hybridoma-zell-linien, die diese monoklonalen antikoerper produzieren
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
ATE80894T1 (de) * 1985-02-05 1992-10-15 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.

Also Published As

Publication number Publication date
GB2168355A (en) 1986-06-18
GB8527466D0 (en) 1985-12-11
ES8801582A1 (es) 1988-02-16
SE8505286D0 (sv) 1985-11-08
AU603053B2 (en) 1990-11-08
FR2572936B1 (fr) 1990-07-20
SE468853B (sv) 1993-03-29
DE3539775C2 (de) 1994-05-26
SE8505286L (sv) 1986-05-10
US5003048A (en) 1991-03-26
ES8703161A1 (es) 1987-02-01
US5030564A (en) 1991-07-09
IT8548762A0 (it) 1985-11-08
KR860006268A (ko) 1986-09-09
ES548727A0 (es) 1987-02-01
US5002878A (en) 1991-03-26
IT1184668B (it) 1987-10-28
ATA327685A (de) 1992-01-15
US5019385A (en) 1991-05-28
AU4970885A (en) 1986-05-15
KR930004596B1 (ko) 1993-06-01
CH664574A5 (fr) 1988-03-15
FR2572936A1 (fr) 1986-05-16
AT395017B (de) 1992-08-25
DE3539775A1 (de) 1986-11-06
GB2168355B (en) 1989-04-19

Similar Documents

Publication Publication Date Title
ES545771A0 (es) Un procedimiento para preparar derivados de quiniona.
ES545440A0 (es) Procedimiento para preparar una composicion de polvo de tan-talo
MX161768A (es) Procedimiento para preparar una composicion desinfectante
ES554625A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
MX161165A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
ES548197A0 (es) Un procedimiento para la preparacion de una composicion terpenico-olefinica sulfurada.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES550113A0 (es) Procedimiento para preparar compuestos carbostirilicos
ES546314A0 (es) Procedimiento para preparar nuevos compuestos de 3-piridilo
ES544615A0 (es) Procedimiento para preparar una composicion antiacido
ES544672A0 (es) Un procedimiento para preparar una composicion de esmalte deunas
ES554812A0 (es) Un procedimiento para preparar una composicion anticariogena solida para administracion oral.
ES554101A0 (es) Un metodo para preparar una composicion dentifrica
MX7466E (es) Procedimiento para preparar una composicion surfactante de almidon
ES525806A0 (es) Un procedimiento para la preparacion de una composicion refractaria de circonio.
ES550819A0 (es) Un procedimiento para preparar nuevos derivados de cefem.
ES554527A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
ES556001A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES557397A0 (es) Un procedimiento para preparar derivados arilicos de diemanidas.
ES554582A0 (es) Procedimiento para preparar una composicion de zirconio
ES556785A0 (es) Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).
ES539543A0 (es) Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona.
AR240018A1 (es) Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
PT81319B (pt) Processo para a preparacao de compostos imunoestimulantes heterociclicos substituidos por peptidios, e de composicoes farmaceuticas contendo estes compostos